These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 8511831

  • 21. [Tumor markers in testicular tumors].
    Jibiki K, Odagiri E, Demura R, Demura H, Yamaguchi Y.
    Gan No Rinsho; 1985 Oct; 31(13):1709-16. PubMed ID: 3841165
    [Abstract] [Full Text] [Related]

  • 22. The utility of lactate dehydrogenase in the follow-up of testicular germ cell tumours.
    Venkitaraman R, Johnson B, Huddart RA, Parker CC, Horwich A, Dearnaley DP.
    BJU Int; 2007 Jul; 100(1):30-2. PubMed ID: 17552950
    [Abstract] [Full Text] [Related]

  • 23. [Tumor marker in urology].
    Shimazaki J, Ito H, Miyauchi T, Maruoka M, Isaka S, Masukagami T, Ando K.
    Gan No Rinsho; 1983 May; 29(6):684-92. PubMed ID: 6192269
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
    Gerl A, Lamerz R, Clemm C, Mann K, Hartenstein R, Wilmanns W.
    Clin Cancer Res; 1996 Sep; 2(9):1565-70. PubMed ID: 9816334
    [Abstract] [Full Text] [Related]

  • 27. [Differentiated teratoma as late recurrence of metastatic non-seminomatous testicular germ cell tumor. Case report and clinical problems].
    Kuczyk MA, Bokemeyer C, Fichna B, Truss M, Schmoll HJ, Jonas U.
    Urologe A; 1995 Nov; 34(6):480-4. PubMed ID: 8848861
    [Abstract] [Full Text] [Related]

  • 28. The value of tumor markers in testicular seminomas. Results of a prospective multicenter study.
    Weissbach L, Bussar-Maatz R, Mann K.
    Eur Urol; 1997 Nov; 32(1):16-22. PubMed ID: 9266226
    [Abstract] [Full Text] [Related]

  • 29. Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA.
    Hautkappe AL, Lu M, Mueller H, Bex A, Harstrick A, Roggendorf M, Ruebben H.
    Cancer Res; 2000 Jun 15; 60(12):3170-4. PubMed ID: 10866307
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. False tumor marker surge evoked by peripheral blood stem cell transplantation.
    Inoue M, Koga F, Kawakami S, Numao N, Sakura M, Kobayashi T, Kihara K.
    Oncologist; 2008 May 15; 13(5):526-9. PubMed ID: 18515737
    [Abstract] [Full Text] [Related]

  • 32. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K, Imamura H, Matsuyama Y, Hasegawa K, Beck Y, Sugawara Y, Makuuchi M, Kokudo N.
    Ann Surg Oncol; 2009 Oct 15; 16(10):2795-804. PubMed ID: 19669841
    [Abstract] [Full Text] [Related]

  • 33. Modified neck dissection for metastatic nonseminomatous testicular carcinoma.
    Weisberger EC, McBride LC.
    Laryngoscope; 1999 Aug 15; 109(8):1241-4. PubMed ID: 10443827
    [Abstract] [Full Text] [Related]

  • 34. Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer.
    Spiess PE, Brown GA, Liu P, Tannir NM, Tu SM, Evans JG, Czerniak B, Kamat AM, Pisters LL.
    Cancer; 2006 Oct 01; 107(7):1483-90. PubMed ID: 16944541
    [Abstract] [Full Text] [Related]

  • 35. The value of serum tumor markers in the staging and prognosis of germ cell tumors of the testis.
    Scardino PT, Cox HD, Waldmann TA, Mcintire KR, Mittemeyer B, Javadpour N.
    J Urol; 1977 Dec 01; 118(6):994-9. PubMed ID: 72833
    [No Abstract] [Full Text] [Related]

  • 36. Benign positive margins after radical prostatectomy means a poor prognosis--pro.
    Djavan B, Milani S, Fong YK.
    Urology; 2005 Feb 01; 65(2):218-20. PubMed ID: 15708025
    [No Abstract] [Full Text] [Related]

  • 37. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
    Kim A, Ji L, Balmaceda C, Diez B, Kellie SJ, Dunkel IJ, Gardner SL, Sposto R, Finlay JL.
    Pediatr Blood Cancer; 2008 Dec 01; 51(6):768-73. PubMed ID: 18802946
    [Abstract] [Full Text] [Related]

  • 38. Tumor markers in testis cancer.
    Klein EA.
    Urol Clin North Am; 1993 Feb 01; 20(1):67-73. PubMed ID: 7679533
    [Abstract] [Full Text] [Related]

  • 39. [Circulating "tumor markers" in gastrointestinal tumors].
    Borlinghaus P, Lamerz R.
    Leber Magen Darm; 1991 Sep 01; 21(5):199-202, 205-6. PubMed ID: 1758235
    [Abstract] [Full Text] [Related]

  • 40. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr 01; 46(2):119-23. PubMed ID: 16638033
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.